XVIPF
Price
$29.84
Change
+$0.19 (+0.64%)
Updated
Jun 26 closing price
Capitalization
905.23M
ZTEK
Price
$1.16
Change
-$0.17 (-12.78%)
Updated
Jun 27, 04:57 PM (EDT)
Capitalization
120.63M
Interact to see
Advertisement

XVIPF vs ZTEK

Header iconXVIPF vs ZTEK Comparison
Open Charts XVIPF vs ZTEKBanner chart's image
Xvivo Perfusion AB
Price$29.84
Change+$0.19 (+0.64%)
Volume$200
Capitalization905.23M
Zentek
Price$1.16
Change-$0.17 (-12.78%)
Volume$100
Capitalization120.63M
XVIPF vs ZTEK Comparison Chart in %
Loading...
ZTEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
XVIPF vs. ZTEK commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is XVIPF is a Hold and ZTEK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (XVIPF: $30.10 vs. ZTEK: $1.16)
Brand notoriety: XVIPF and ZTEK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: XVIPF: 16% vs. ZTEK: 203%
Market capitalization -- XVIPF: $905.23M vs. ZTEK: $120.63M
XVIPF [@Medical Specialties] is valued at $905.23M. ZTEK’s [@Medical Specialties] market capitalization is $120.63M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

XVIPF’s FA Score shows that 0 FA rating(s) are green whileZTEK’s FA Score has 0 green FA rating(s).

  • XVIPF’s FA Score: 0 green, 5 red.
  • ZTEK’s FA Score: 0 green, 5 red.
According to our system of comparison, ZTEK is a better buy in the long-term than XVIPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ZTEK’s TA Score shows that 4 TA indicator(s) are bullish.

  • ZTEK’s TA Score: 4 bullish, 5 bearish.

Price Growth

XVIPF (@Medical Specialties) experienced а -8.51% price change this week, while ZTEK (@Medical Specialties) price change was -12.13% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +1.35%, and the average quarterly price growth was -0.23%.

Industries' Descriptions

@Medical Specialties (+1.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XVIPF($905M) has a higher market cap than ZTEK($121M). ZTEK YTD gains are higher at: 23.394 vs. XVIPF (-26.764). XVIPF has higher annual earnings (EBITDA): 29.2M vs. ZTEK (-11.39M). XVIPF has more cash in the bank: 171M vs. ZTEK (5.35M). ZTEK has less debt than XVIPF: ZTEK (1.28M) vs XVIPF (27.6M). XVIPF has higher revenues than ZTEK: XVIPF (524M) vs ZTEK (48.6K).
XVIPFZTEKXVIPF / ZTEK
Capitalization905M121M748%
EBITDA29.2M-11.39M-256%
Gain YTD-26.76423.394-114%
P/E Ratio344.83N/A-
Revenue524M48.6K1,078,189%
Total Cash171M5.35M3,199%
Total Debt27.6M1.28M2,163%
FUNDAMENTALS RATINGS
XVIPF vs ZTEK: Fundamental Ratings
XVIPF
ZTEK
OUTLOOK RATING
1..100
3362
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
6282
SMR RATING
1..100
7997
PRICE GROWTH RATING
1..100
8546
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZTEK's Valuation (68) in the null industry is in the same range as XVIPF (91). This means that ZTEK’s stock grew similarly to XVIPF’s over the last 12 months.

XVIPF's Profit vs Risk Rating (62) in the null industry is in the same range as ZTEK (82). This means that XVIPF’s stock grew similarly to ZTEK’s over the last 12 months.

XVIPF's SMR Rating (79) in the null industry is in the same range as ZTEK (97). This means that XVIPF’s stock grew similarly to ZTEK’s over the last 12 months.

ZTEK's Price Growth Rating (46) in the null industry is somewhat better than the same rating for XVIPF (85). This means that ZTEK’s stock grew somewhat faster than XVIPF’s over the last 12 months.

XVIPF's P/E Growth Rating (95) in the null industry is in the same range as ZTEK (100). This means that XVIPF’s stock grew similarly to ZTEK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ZTEK
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ZTEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PXIIX21.70N/A
N/A
Virtus KAR Equity Income I
NBMIX48.47N/A
N/A
Neuberger Berman Small Cap Growth Inv
CLGPX16.87N/A
N/A
Columbia Large Cap Growth Opp R
RREMX15.30N/A
N/A
RBC Emerging Markets Equity R6
MSVMX5.23N/A
N/A
Morgan Stanley Vitality Portfolio C

XVIPF and

Correlation & Price change

A.I.dvisor tells us that XVIPF and USAQ have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XVIPF and USAQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XVIPF
1D Price
Change %
XVIPF100%
+0.88%
USAQ - XVIPF
22%
Poorly correlated
N/A
VYCO - XVIPF
17%
Poorly correlated
N/A
ZTEK - XVIPF
9%
Poorly correlated
-12.79%
LUNG - XVIPF
6%
Poorly correlated
+0.19%
VPTDF - XVIPF
2%
Poorly correlated
-3.78%
More

ZTEK and

Correlation & Price change

A.I.dvisor tells us that ZTEK and TLTFF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZTEK and TLTFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTEK
1D Price
Change %
ZTEK100%
-12.79%
TLTFF - ZTEK
27%
Poorly correlated
-7.79%
VERO - ZTEK
25%
Poorly correlated
-2.27%
RVTY - ZTEK
25%
Poorly correlated
-0.98%
NVNO - ZTEK
25%
Poorly correlated
-4.27%
INGN - ZTEK
23%
Poorly correlated
-1.60%
More